These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. Kappenberger LJ, Fromer MA, Steinbrunn W, Shenasa M. Am J Cardiol; 1984 Aug 01; 54(3):330-5. PubMed ID: 6465013 [Abstract] [Full Text] [Related]
4. Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias. Finerman WB, Hamer A, Peter T, Weiss D, Mandel WJ. Am Heart J; 1982 Nov 01; 104(5 Pt 1):987-96. PubMed ID: 7137016 [Abstract] [Full Text] [Related]
7. Mechanism of double ventricular response to a single atrial extrastimulus in patients with Wolff-Parkinson-White syndrome. Matsuhisa M, Shimomura K, Ohe T, Kamakura S, Aihara N. Pacing Clin Electrophysiol; 1990 Apr 01; 13(4):443-52. PubMed ID: 1692128 [Abstract] [Full Text] [Related]
8. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome. Brugada P, Wellens HJ. Am J Cardiol; 1985 Nov 15; 56(13):863-6. PubMed ID: 4061328 [Abstract] [Full Text] [Related]
9. Effect of amiodarone in the Wolff-Parkinson-White syndrome. Wellens HJ, Lie KI, Bär FW, Wesdorp JC, Dohmen HJ, Düren DR, Durrer D. Am J Cardiol; 1976 Aug 15; 38(2):189-94. PubMed ID: 952262 [Abstract] [Full Text] [Related]
10. The role of an accessory atrioventricular pathway in reciprocal tachycardia. Observations in patients with and without the Wolff-Parkinson-White syndrome. Wellens HJ, Durrer D. Circulation; 1975 Jul 15; 52(1):58-72. PubMed ID: 1132122 [Abstract] [Full Text] [Related]
11. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. Wellens HJ, Brugada P, Abdollah H, Dassen WR. Circulation; 1984 Jan 15; 69(1):120-4. PubMed ID: 6689635 [Abstract] [Full Text] [Related]
13. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia. Chen SA, Chiang CE, Tai CT, Lee SH, Chiou CW, Ueng KC, Wen ZC, Cheng CC, Chang MS. Circulation; 1996 Jun 01; 93(11):2023-32. PubMed ID: 8640978 [Abstract] [Full Text] [Related]
14. Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Sharpe MD, Cuillerier DJ, Lee JK, Basta M, Krahn AD, Klein GJ, Yee R. Anesthesiology; 1999 Jan 01; 90(1):60-5. PubMed ID: 9915313 [Abstract] [Full Text] [Related]
15. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome. Milstein S, Klein GJ, Rattes MF, Sharma AD, Yee R. J Am Coll Cardiol; 1987 Dec 01; 10(6):1244-8. PubMed ID: 3680792 [Abstract] [Full Text] [Related]
16. Intravenous amiodarone in the acute termination of supraventricular arrhythmias. Holt P, Crick JC, Davies DW, Curry P. Int J Cardiol; 1985 May 01; 8(1):67-79. PubMed ID: 3997293 [Abstract] [Full Text] [Related]
17. Study of Wolff-Parkinson-White syndrome by transesophageal pacing and assessment of long-term amiodarone therapy. Gonzalez MD, Guillen RH, Pellizzon OA, Raimondi EC. Am J Cardiol; 1985 Mar 01; 55(6):852-6. PubMed ID: 3976536 [No Abstract] [Full Text] [Related]
19. Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart. Shenasa M, Denker S, Mahmud R, Lehmann M, Estrada A, Akhtar M. J Am Coll Cardiol; 1984 Jul 01; 4(1):105-10. PubMed ID: 6736436 [Abstract] [Full Text] [Related]
20. Two accessory pathways, dual AV nodal conduction, and 1:2 ventriculoatrial conduction in a patient with multiple supraventricular tachycardias. Rosenfeld LE, Batsford WP. Pacing Clin Electrophysiol; 1990 Feb 01; 13(2):171-8. PubMed ID: 1689833 [Abstract] [Full Text] [Related] Page: [Next] [New Search]